Whitehawk Therapeutics, Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| 2,389.2% | 5,199.7% | – | – | – | – | – | – | 7.8% | 9.9% | 14.0% | 4.2% | 9.0% | 225.3% | 211.2% | 216.5% | 266.1% | 224.5% | 149.8% | 209.1% | 10.6% | – | – | – | – | – | – | |
| -2,289.2% | -5,099.7% | – | 100.0% | – | – | – | 100.0% | 92.2% | 90.1% | 86.0% | 95.8% | 91.0% | -125.3% | -111.2% | -116.5% | -166.1% | -124.5% | -49.8% | -109.1% | 89.4% | – | – | – | – | – | – | |
| 2,389.2% | 5,199.7% | – | 38.0% | – | – | – | 722.7% | 294.5% | 224.8% | 206.7% | 179.3% | 186.7% | 214.7% | 199.5% | 201.8% | 253.9% | 211.9% | 138.6% | 198.2% | 123.0% | – | – | – | – | – | – | |
| 608.2% | 590.0% | – | 3.0% | – | – | – | 971.8% | 396.5% | – | – | – | – | – | 188.3% | 163.5% | 198.4% | 127.7% | 99.6% | 152.7% | 179.4% | – | – | – | – | – | – | |
| 608.2% | 590.0% | – | 40.0% | – | – | – | 1,694.5% | 691.0% | 624.3% | 440.2% | 391.8% | 377.8% | 189.9% | 188.3% | 163.5% | 198.4% | 127.7% | 136.2% | 152.7% | 302.4% | – | – | – | – | – | – | |
| -2,897.4% | -5,689.7% | – | 60.0% | – | – | – | -1,594.5% | -598.8% | -534.2% | -354.2% | -296.0% | -286.8% | -315.1% | -299.5% | -280.0% | -364.5% | -252.2% | -186.0% | -261.8% | -213.0% | – | – | – | – | – | – | |
| 109.0% | 219.8% | – | 1.6% | – | – | – | 5.7% | 2.5% | 1.7% | 1.4% | 1.1% | 1.0% | 0.9% | 1.0% | 0.9% | 1.1% | 0.9% | 0.5% | 0.0% | 0.0% | – | – | – | – | – | – | |
| -3,006.4% | -5,909.5% | – | 57.3% | – | – | – | -1,599.0% | -600.7% | -531.3% | -341.0% | -266.3% | -259.5% | -289.8% | -273.6% | -257.2% | -341.7% | -236.0% | -174.0% | -252.4% | 1,021.9% | – | – | – | – | – | – | |
| – | – | – | 0.0% | – | – | – | – | – | 0.3% | – | -0.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -3,006.4% | -5,909.5% | – | 57.3% | – | – | – | -1,599.0% | -600.7% | -531.5% | -341.0% | -266.2% | -259.5% | -289.8% | -273.6% | -257.2% | -341.7% | -236.0% | -174.0% | -252.4% | 1,021.9% | – | – | – | – | – | – | |
| -2,895.4% | -5,687.2% | – | 59.0% | – | – | – | -1,586.1% | -594.9% | -528.8% | -339.3% | -264.4% | -257.8% | -288.1% | -271.9% | -255.6% | -339.6% | -234.3% | -148.8% | -251.8% | 1,022.6% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.